SCIENCE

SELECT TOPIC

Featured All Brain Cancer Breast Cancer Cancer Clinical Study Colorectal Cancer Combination Therapy Drug Development Immunotherapy Kinase Inhibitors Lung Cancer Mechanism of Action Metastatic Cancer Microdevice Neuroscience Ovarian Cancer Pancreatic Cancer Personalized Oncology Rare Cancers Renal Cancer Technology Development Triple-Negative Breast Cancer

SCIENCE

SELECT TOPIC

SELECT TYPE

ALL

Preparation and sterilization of an implantable drug delivery microdevice for clinical use

The translational and regulatory development of an implantable microdevice for multiple drug senstitivity measurements in cancer patients

Self expanding anchors for stabilizing percutaneously implanted microdevices in biological tissues

A miniaturized platform for multiplexed drug response imaging in live tumors

REV1 inhibitor JH-RE-06 enhances tumor cell response to chemotherapy by triggering senescence hallmarks

Genome-wide interrogation of human cancers identifies EGLN1 dependency in clear cell ovarian cancers

VISAGE reveals a targetable mitotic spindle vulnerability in cancer cells

An interventional image-guided microdevice implantation and retrieval method for in vivo drug response assessment

In vivo detection of drug-induced apoptosis in tumors using Raman spectroscopy

Tyrosine Kinase Inhibitors Increase MCL1 Degradation and in Combination with BCLXL/BCL2 Inhibitors Drive Prostate Cancer Apoptosis

Microenvironment-Mediated Mechanisms of Resistance to HER2 Inhibitors Differ between HER2+ Breast Cancer Subtypes

Direct evidence for cancer-cell-autonomous extracellular protein catabolism in pancreatic tumors

Synergistic interactions with PI3K inhibition that induce apoptosis

Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine

MENA Confers Resistance to Paclitaxel in Triple-Negative Breast Cancer

SELECT TOPIC

SELECT TYPE